世界の腹膜がん市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Peritoneal Cancer Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4525
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、腹膜がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、化学療法（抗がん剤）、放射線療法（高エネルギー光線））、用途別市場規模（がん研究センター、がん病院、手術センター、診療所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・腹膜がんの市場動向
・企業の競争状況、市場シェア
・腹膜がんの種類別市場規模（手術、化学療法（抗がん剤）、放射線療法（高エネルギー光線））
・腹膜がんの用途別市場規模（がん研究センター、がん病院、手術センター、診療所）
・腹膜がんの北米市場規模2016-2027（アメリカ、カナダ）
・腹膜がんのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・腹膜がんのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・腹膜がんの中南米市場規模2016-2027（メキシコ、ブラジル）
・腹膜がんの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AstraZeneca、GlaxoSmithKline、Oxford BioMedica、Millennium Pharmaceuticals、Novartis、Bayer、Incyte、EntreMed、Oncolytics Biotech、Synta Pharmaceuticals、Oasmia Pharmaceutical）
・結論

Peritoneal cancer is also known as serous surface papillary carcinoma, primary peritoneal carcinoma, extra-ovarian serous carcinoma, primary serous papillary carcinoma and psammomacarcinoma.
Peritoneal cancer develops in a thin layer of tissue that lines the abdomen. It also covers the uterus, bladder and rectum.

Market Analysis and Insights: Global Peritoneal Cancer Market
The global Peritoneal Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peritoneal Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peritoneal Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peritoneal Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peritoneal Cancer market.

Global Peritoneal Cancer Scope and Market Size
Peritoneal Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peritoneal Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgery
Chemotherapy (Anticancer Drugs)
Radiotherapy (High-Energy Rays)

Segment by Application
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
GlaxoSmithKline
Oxford BioMedica
Millennium Pharmaceuticals
Novartis
Bayer
Incyte
EntreMed
Oncolytics Biotech

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peritoneal Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Chemotherapy (Anticancer Drugs)
1.2.4 Radiotherapy (High-Energy Rays)
1.3 Market by Application
1.3.1 Global Peritoneal Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer Research Centers
1.3.3 Cancer Hospital
1.3.4 Surgical Centers
1.3.5 Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Peritoneal Cancer Market Perspective (2016-2027)
2.2 Peritoneal Cancer Growth Trends by Regions
2.2.1 Peritoneal Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peritoneal Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Peritoneal Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Peritoneal Cancer Industry Dynamic
2.3.1 Peritoneal Cancer Market Trends
2.3.2 Peritoneal Cancer Market Drivers
2.3.3 Peritoneal Cancer Market Challenges
2.3.4 Peritoneal Cancer Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Peritoneal Cancer Players by Revenue
3.1.1 Global Top Peritoneal Cancer Players by Revenue (2016-2021)
3.1.2 Global Peritoneal Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Peritoneal Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peritoneal Cancer Revenue
3.4 Global Peritoneal Cancer Market Concentration Ratio
3.4.1 Global Peritoneal Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peritoneal Cancer Revenue in 2020
3.5 Peritoneal Cancer Key Players Head office and Area Served
3.6 Key Players Peritoneal Cancer Product Solution and Service
3.7 Date of Enter into Peritoneal Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Peritoneal Cancer Breakdown Data by Type
4.1 Global Peritoneal Cancer Historic Market Size by Type (2016-2021)
4.2 Global Peritoneal Cancer Forecasted Market Size by Type (2022-2027)

5 Peritoneal Cancer Breakdown Data by Application
5.1 Global Peritoneal Cancer Historic Market Size by Application (2016-2021)
5.2 Global Peritoneal Cancer Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Peritoneal Cancer Market Size (2016-2027)
6.2 North America Peritoneal Cancer Market Size by Type
6.2.1 North America Peritoneal Cancer Market Size by Type (2016-2021)
6.2.2 North America Peritoneal Cancer Market Size by Type (2022-2027)
6.2.3 North America Peritoneal Cancer Market Size by Type (2016-2027)
6.3 North America Peritoneal Cancer Market Size by Application
6.3.1 North America Peritoneal Cancer Market Size by Application (2016-2021)
6.3.2 North America Peritoneal Cancer Market Size by Application (2022-2027)
6.3.3 North America Peritoneal Cancer Market Size by Application (2016-2027)
6.4 North America Peritoneal Cancer Market Size by Country
6.4.1 North America Peritoneal Cancer Market Size by Country (2016-2021)
6.4.2 North America Peritoneal Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Peritoneal Cancer Market Size (2016-2027)
7.2 Europe Peritoneal Cancer Market Size by Type
7.2.1 Europe Peritoneal Cancer Market Size by Type (2016-2021)
7.2.2 Europe Peritoneal Cancer Market Size by Type (2022-2027)
7.2.3 Europe Peritoneal Cancer Market Size by Type (2016-2027)
7.3 Europe Peritoneal Cancer Market Size by Application
7.3.1 Europe Peritoneal Cancer Market Size by Application (2016-2021)
7.3.2 Europe Peritoneal Cancer Market Size by Application (2022-2027)
7.3.3 Europe Peritoneal Cancer Market Size by Application (2016-2027)
7.4 Europe Peritoneal Cancer Market Size by Country
7.4.1 Europe Peritoneal Cancer Market Size by Country (2016-2021)
7.4.2 Europe Peritoneal Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Peritoneal Cancer Market Size (2016-2027)
8.2 Asia-Pacific Peritoneal Cancer Market Size by Type
8.2.1 Asia-Pacific Peritoneal Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peritoneal Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peritoneal Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Peritoneal Cancer Market Size by Application
8.3.1 Asia-Pacific Peritoneal Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peritoneal Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peritoneal Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Peritoneal Cancer Market Size by Region
8.4.1 Asia-Pacific Peritoneal Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peritoneal Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Peritoneal Cancer Market Size (2016-2027)
9.2 Latin America Peritoneal Cancer Market Size by Type
9.2.1 Latin America Peritoneal Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Peritoneal Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Peritoneal Cancer Market Size by Type (2016-2027)
9.3 Latin America Peritoneal Cancer Market Size by Application
9.3.1 Latin America Peritoneal Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Peritoneal Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Peritoneal Cancer Market Size by Application (2016-2027)
9.4 Latin America Peritoneal Cancer Market Size by Country
9.4.1 Latin America Peritoneal Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Peritoneal Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Peritoneal Cancer Market Size (2016-2027)
10.2 Middle East & Africa Peritoneal Cancer Market Size by Type
10.2.1 Middle East & Africa Peritoneal Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peritoneal Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peritoneal Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Peritoneal Cancer Market Size by Application
10.3.1 Middle East & Africa Peritoneal Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peritoneal Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peritoneal Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Peritoneal Cancer Market Size by Country
10.4.1 Middle East & Africa Peritoneal Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peritoneal Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Peritoneal Cancer Introduction
11.1.4 AstraZeneca Revenue in Peritoneal Cancer Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Peritoneal Cancer Introduction
11.2.4 GlaxoSmithKline Revenue in Peritoneal Cancer Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Oxford BioMedica
11.3.1 Oxford BioMedica Company Details
11.3.2 Oxford BioMedica Business Overview
11.3.3 Oxford BioMedica Peritoneal Cancer Introduction
11.3.4 Oxford BioMedica Revenue in Peritoneal Cancer Business (2016-2021)
11.3.5 Oxford BioMedica Recent Development
11.4 Millennium Pharmaceuticals
11.4.1 Millennium Pharmaceuticals Company Details
11.4.2 Millennium Pharmaceuticals Business Overview
11.4.3 Millennium Pharmaceuticals Peritoneal Cancer Introduction
11.4.4 Millennium Pharmaceuticals Revenue in Peritoneal Cancer Business (2016-2021)
11.4.5 Millennium Pharmaceuticals Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Peritoneal Cancer Introduction
11.5.4 Novartis Revenue in Peritoneal Cancer Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Peritoneal Cancer Introduction
11.6.4 Bayer Revenue in Peritoneal Cancer Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Incyte
11.7.1 Incyte Company Details
11.7.2 Incyte Business Overview
11.7.3 Incyte Peritoneal Cancer Introduction
11.7.4 Incyte Revenue in Peritoneal Cancer Business (2016-2021)
11.7.5 Incyte Recent Development
11.8 EntreMed
11.8.1 EntreMed Company Details
11.8.2 EntreMed Business Overview
11.8.3 EntreMed Peritoneal Cancer Introduction
11.8.4 EntreMed Revenue in Peritoneal Cancer Business (2016-2021)
11.8.5 EntreMed Recent Development
11.9 Oncolytics Biotech
11.9.1 Oncolytics Biotech Company Details
11.9.2 Oncolytics Biotech Business Overview
11.9.3 Oncolytics Biotech Peritoneal Cancer Introduction
11.9.4 Oncolytics Biotech Revenue in Peritoneal Cancer Business (2016-2021)
11.9.5 Oncolytics Biotech Recent Development
11.10 Synta Pharmaceuticals
11.10.1 Synta Pharmaceuticals Company Details
11.10.2 Synta Pharmaceuticals Business Overview
11.10.3 Synta Pharmaceuticals Peritoneal Cancer Introduction
11.10.4 Synta Pharmaceuticals Revenue in Peritoneal Cancer Business (2016-2021)
11.10.5 Synta Pharmaceuticals Recent Development
11.11 Oasmia Pharmaceutical
11.11.1 Oasmia Pharmaceutical Company Details
11.11.2 Oasmia Pharmaceutical Business Overview
11.11.3 Oasmia Pharmaceutical Peritoneal Cancer Introduction
11.11.4 Oasmia Pharmaceutical Revenue in Peritoneal Cancer Business (2016-2021)
11.11.5 Oasmia Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Peritoneal Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Chemotherapy (Anticancer Drugs)
Table 4. Key Players of Radiotherapy (High-Energy Rays)
Table 5. Global Peritoneal Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Peritoneal Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Peritoneal Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Peritoneal Cancer Market Share by Regions (2016-2021)
Table 9. Global Peritoneal Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Peritoneal Cancer Market Share by Regions (2022-2027)
Table 11. Peritoneal Cancer Market Trends
Table 12. Peritoneal Cancer Market Drivers
Table 13. Peritoneal Cancer Market Challenges
Table 14. Peritoneal Cancer Market Restraints
Table 15. Global Peritoneal Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Peritoneal Cancer Market Share by Players (2016-2021)
Table 17. Global Top Peritoneal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peritoneal Cancer as of 2020)
Table 18. Ranking of Global Top Peritoneal Cancer Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Peritoneal Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Peritoneal Cancer Product Solution and Service
Table 22. Date of Enter into Peritoneal Cancer Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peritoneal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Peritoneal Cancer Revenue Market Share by Type (2016-2021)
Table 26. Global Peritoneal Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Peritoneal Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Peritoneal Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Peritoneal Cancer Revenue Market Share by Application (2016-2021)
Table 30. Global Peritoneal Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Peritoneal Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Peritoneal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Peritoneal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Peritoneal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Peritoneal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Peritoneal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Peritoneal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Peritoneal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Peritoneal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Peritoneal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Peritoneal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Peritoneal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Peritoneal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Peritoneal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Peritoneal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Peritoneal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Peritoneal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Peritoneal Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Peritoneal Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Peritoneal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Peritoneal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Peritoneal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Peritoneal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Peritoneal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Peritoneal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Peritoneal Cancer Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Peritoneal Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Peritoneal Cancer Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Peritoneal Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Peritoneal Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Peritoneal Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Peritoneal Cancer Product
Table 65. AstraZeneca Revenue in Peritoneal Cancer Business (2016-2021) & (US$ Million)
Table 66. AstraZeneca Recent Development
Table 67. GlaxoSmithKline Company Details
Table 68. GlaxoSmithKline Business Overview
Table 69. GlaxoSmithKline Peritoneal Cancer Product
Table 70. GlaxoSmithKline Revenue in Peritoneal Cancer Business (2016-2021) & (US$ Million)
Table 71. GlaxoSmithKline Recent Development
Table 72. Oxford BioMedica Company Details
Table 73. Oxford BioMedica Business Overview
Table 74. Oxford BioMedica Peritoneal Cancer Product
Table 75. Oxford BioMedica Revenue in Peritoneal Cancer Business (2016-2021) & (US$ Million)
Table 76. Oxford BioMedica Recent Development
Table 77. Millennium Pharmaceuticals Company Details
Table 78. Millennium Pharmaceuticals Business Overview
Table 79. Millennium Pharmaceuticals Peritoneal Cancer Product
Table 80. Millennium Pharmaceuticals Revenue in Peritoneal Cancer Business (2016-2021) & (US$ Million)
Table 81. Millennium Pharmaceuticals Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Peritoneal Cancer Product
Table 85. Novartis Revenue in Peritoneal Cancer Business (2016-2021) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Bayer Company Details
Table 88. Bayer Business Overview
Table 89. Bayer Peritoneal Cancer Product
Table 90. Bayer Revenue in Peritoneal Cancer Business (2016-2021) & (US$ Million)
Table 91. Bayer Recent Development
Table 92. Incyte Company Details
Table 93. Incyte Business Overview
Table 94. Incyte Peritoneal Cancer Product
Table 95. Incyte Revenue in Peritoneal Cancer Business (2016-2021) & (US$ Million)
Table 96. Incyte Recent Development
Table 97. EntreMed Company Details
Table 98. EntreMed Business Overview
Table 99. EntreMed Revenue in Peritoneal Cancer Business (2016-2021) & (US$ Million)
Table 100. EntreMed Recent Development
Table 101. Oncolytics Biotech Company Details
Table 102. Oncolytics Biotech Business Overview
Table 103. Oncolytics Biotech Peritoneal Cancer Product
Table 104. Oncolytics Biotech Revenue in Peritoneal Cancer Business (2016-2021) & (US$ Million)
Table 105. Oncolytics Biotech Recent Development
Table 106. Synta Pharmaceuticals Company Details
Table 107. Synta Pharmaceuticals Business Overview
Table 108. Synta Pharmaceuticals Peritoneal Cancer Product
Table 109. Synta Pharmaceuticals Revenue in Peritoneal Cancer Business (2016-2021) & (US$ Million)
Table 110. Synta Pharmaceuticals Recent Development
Table 111. Oasmia Pharmaceutical Company Details
Table 112. Oasmia Pharmaceutical Business Overview
Table 113. Oasmia Pharmaceutical Peritoneal Cancer Product
Table 114. Oasmia Pharmaceutical Revenue in Peritoneal Cancer Business (2016-2021) & (US$ Million)
Table 115. Oasmia Pharmaceutical Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peritoneal Cancer Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Chemotherapy (Anticancer Drugs) Features
Figure 4. Radiotherapy (High-Energy Rays) Features
Figure 5. Global Peritoneal Cancer Market Share by Application: 2020 VS 2027
Figure 6. Cancer Research Centers Case Studies
Figure 7. Cancer Hospital Case Studies
Figure 8. Surgical Centers Case Studies
Figure 9. Clinics Case Studies
Figure 10. Peritoneal Cancer Report Years Considered
Figure 11. Global Peritoneal Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Peritoneal Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Peritoneal Cancer Market Share by Regions: 2020 VS 2027
Figure 14. Global Peritoneal Cancer Market Share by Regions (2022-2027)
Figure 15. Global Peritoneal Cancer Market Share by Players in 2020
Figure 16. Global Top Peritoneal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peritoneal Cancer as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Peritoneal Cancer Revenue in 2020
Figure 18. Global Peritoneal Cancer Revenue Market Share by Type (2016-2021)
Figure 19. Global Peritoneal Cancer Revenue Market Share by Type (2022-2027)
Figure 20. North America Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Peritoneal Cancer Market Share by Type (2016-2027)
Figure 22. North America Peritoneal Cancer Market Share by Application (2016-2027)
Figure 23. North America Peritoneal Cancer Market Share by Country (2016-2027)
Figure 24. United States Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Peritoneal Cancer Market Share by Type (2016-2027)
Figure 28. Europe Peritoneal Cancer Market Share by Application (2016-2027)
Figure 29. Europe Peritoneal Cancer Market Share by Country (2016-2027)
Figure 30. Germany Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Peritoneal Cancer Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Peritoneal Cancer Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Peritoneal Cancer Market Share by Region (2016-2027)
Figure 40. China Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Peritoneal Cancer Market Share by Type (2016-2027)
Figure 48. Latin America Peritoneal Cancer Market Share by Application (2016-2027)
Figure 49. Latin America Peritoneal Cancer Market Share by Country (2016-2027)
Figure 50. Mexico Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Peritoneal Cancer Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Peritoneal Cancer Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Peritoneal Cancer Market Share by Country (2016-2027)
Figure 56. Turkey Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Peritoneal Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AstraZeneca Revenue Growth Rate in Peritoneal Cancer Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Peritoneal Cancer Business (2016-2021)
Figure 61. Oxford BioMedica Revenue Growth Rate in Peritoneal Cancer Business (2016-2021)
Figure 62. Millennium Pharmaceuticals Revenue Growth Rate in Peritoneal Cancer Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Peritoneal Cancer Business (2016-2021)
Figure 64. Bayer Revenue Growth Rate in Peritoneal Cancer Business (2016-2021)
Figure 65. Incyte Revenue Growth Rate in Peritoneal Cancer Business (2016-2021)
Figure 66. EntreMed Revenue Growth Rate in Peritoneal Cancer Business (2016-2021)
Figure 67. Oncolytics Biotech Revenue Growth Rate in Peritoneal Cancer Business (2016-2021)
Figure 68. Synta Pharmaceuticals Revenue Growth Rate in Peritoneal Cancer Business (2016-2021)
Figure 69. Oasmia Pharmaceutical Revenue Growth Rate in Peritoneal Cancer Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の自動腹膜透析（APD）市場 2021：企業別、地域別、種類・用途別

Global Automated Peritoneal Dialysis (APD) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z01250 2021年4月 105Pages
当調査資料では、自動腹膜透析（APD）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。自動腹膜透析（APD）の種類別市場規模（大型、小型）、用途別市場規模（昼間用、夜間用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南...

世界の上咽頭がん市場規模・現状・予測（2021年-2027年）

Global Nasopharyngeal Cancer Market Size, Status and Forecast 2021-2027
QYR2104Z4029 2021年4月 98Pages
QYResearch社発行の本調査資料では、上咽頭がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、放射線、化学療法）、用途別市場規模（病院、診療所、がん治療・リハビリテーションセンター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の上咽頭がん市場規模・現状・予測（2021年-2027年）

世界の下咽頭がん治療市場規模・現状・予測（2021年-2027年）

Global Hypopharyngeal Cancer Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3007 2021年4月 99Pages
QYResearch社発行の本調査資料では、下咽頭がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ガネテスピブ、PGV-001、ニモツズマブ、CDX-3379、その他）、用途別市場規模（外来患者、入院患者）、主要地域別市場規模（北米、ア...

世界の陰茎がん市場規模・現状・予測（2021年-2027年）

Global Penile Cancer Market Size, Status and Forecast 2021-2027
QYR2104Z4493 2021年4月 91Pages
QYResearch社発行の本調査資料では、陰茎がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（放射線療法、化学療法、生物学的療法、手術）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界の膀胱がん治療市場規模・現状・予測（2021年-2027年）

Global Bladder Cancer Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0872 2021年4月 95Pages
QYResearch社発行の本調査資料では、膀胱がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（移行上皮がん、浸潤性膀胱がん、表在性膀胱がん、扁平上皮がん、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、...

世界の卵巣がん遺伝子治療市場規模・現状・予測（2021年-2027年）

Global Gene Therapy for Ovarian Cancer Market Size, Status and Forecast 2021-2027
QYR2104Z2521 2021年4月 99Pages
QYResearch社発行の本調査資料では、卵巣がん遺伝子治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、腫瘍内、腹腔内）、用途別市場規模（卵巣がん（詳細不明）、再発卵巣上皮がん、プラチナ耐性卵巣がん）、主要地域別市場規模（北米、ア...

世界の肛門がん治療薬市場規模・現状・予測（2021年-2027年）

Global Anal Cancer Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z0308 2021年4月 98Pages
QYResearch社発行の本調査資料では、肛門がん治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（フルオロウラシル、シスプラチン、カルボプラチン）、用途別市場規模（病院、介護センター、薬局、診断研究所）、主要地域別市場規模（北米、アメリ...

世界の結腸がん市場規模・現状・予測（2021年-2027年）

Global Colon Cancer Market Size, Status and Forecast 2021-2027
QYR2104Z1446 2021年4月 98Pages
QYResearch社発行の本調査資料では、結腸がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手術、化学療法、放射線）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、...

世界の陰茎がん治療市場規模・現状・予測（2021年-2027年）

Global Penile Cancer Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4494 2021年4月 92Pages
QYResearch社発行の本調査資料では、陰茎がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（放射線療法、化学療法、生物学的療法、手術）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung Cancer Treatment Drugs are durgs used to cure lung cancer. In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing…
世界の肺がん市場規模・現状・予測（2021年-2027年） Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as prim…
世界の甲状腺がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Thyroid Cancer Treatment Market The global Thyroid Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …
世界の肺がん手術市場規模・現状・予測（2021年-2027年） Lung adenocarcinoma is a type of lung cancer and belongs to non-small cell carcinoma. North America dominates the global lung cancer surgery market. Growth in the North American segment is primarily driven by the rapid growth in the aging population, availability of reimbursement for lung cancer sur…
世界の頭頸部がん治療薬/治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Head and Neck Cancer Drugs/Therapeutics Market The global Head and Neck Cancer Drugs/Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…